Cargando…

Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma

BACKGROUND: Glioblastoma (GBM) has been extensively researched over the last few decades, yet despite aggressive multimodal treatment, recurrence is inevitable and second-line treatment options are limited. Here, we demonstrate how high-throughput screening (HTS) in multicellular spheroids can gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Jessica T, Ellison, Stuart, Pandele, Alina, Wood, Shaun, Nathan, Erica, Forte, Gabriella, Parker, Helen, Zindy, Egor, Elvin, Mark, Dickson, Alan, Williams, Kaye J, Karabatsou, Konstantina, McCabe, Martin, McBain, Catherine, Bigger, Brian W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523458/ https://www.ncbi.nlm.nih.gov/pubmed/32227096 http://dx.doi.org/10.1093/neuonc/noaa051

Ejemplares similares

Discovery of actinomycin L, a new member of the actinomycin family of antibiotics
por: Machushynets, Nataliia V., et al.
Publicado: (2022)

Genetic interrelations in the actinomycin biosynthetic gene clusters of Streptomyces antibioticus IMRU 3720 and Streptomyces chrysomallus ATCC11523, producers of actinomycin X and actinomycin C
por: Crnovčić, Ivana, et al.
Publicado: (2017)

ON THE DIFFERENTIAL CYTOTOXICITY OF ACTINOMYCIN D
por: Sawicki, Stanley G., et al.
Publicado: (1971)

In vitro and in silico evaluations of actinomycin X(2)and actinomycin D as potent anti-tuberculosis agents
por: Qureshi, Kamal Ahmad, et al.
Publicado: (2023)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

Sex as a Biological Variable in Preclinical Modeling of Blast-Related Traumatic Brain Injury
por: McCabe, Joseph T., et al.
Publicado: (2020)

Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma
por: McCabe, Martin G., et al.
Publicado: (2011)

Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models
por: Martínez-Pérez, Carlos, et al.
Publicado: (2016)

Use of Preclinical Models to Improve Treatment of Retinoblastoma
por: Dyer, Michael A, et al.
Publicado: (2005)

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
por: Xiang, R, et al.
Publicado: (2011)

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
por: Tavanti, E, et al.
Publicado: (2013)

Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer
por: Hill, Christopher R., et al.
Publicado: (2014)

Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin
por: Li, X M, et al.
Publicado: (2005)

THE RADIOAUTOGRAPHIC DETECTION OF DNA WITH TRITIATED ACTINOMYCIN D
por: Camargo, E. Plessmann, et al.
Publicado: (1967)

ON THE RECOVERY OF TRANSCRIPTION AFTER INHIBITION BY ACTINOMYCIN D
por: Sawicki, Stanley G., et al.
Publicado: (1972)

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
por: Garrido-Laguna, I, et al.
Publicado: (2010)

THE EFFECTS OF ACTINOMYCIN D ON PROTEIN SYNTHESIS AND BEATING IN CULTURED RAT HEART CELLS
por: McCarl, Richard L., et al.
Publicado: (1969)

Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours
por: Hussein, D, et al.
Publicado: (2009)

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
por: Belgiovine, Cristina, et al.
Publicado: (2017)

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis
por: Li, Ka-Loh, et al.
Publicado: (2016)

Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026
por: Nutley, B P, et al.
Publicado: (2005)

A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
por: Mercalli, A, et al.
Publicado: (2007)

Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
por: Parra, Karla, et al.
Publicado: (2017)

DEGRADATION OF RIBONUCLEIC ACID IN MOUSE FIBROBLASTS TREATED WITH ACTINOMYCIN
por: Wiesner, R., et al.
Publicado: (1965)

DNA DEPENDENCE OF PLASTID DIFFERENTIATION INHIBITION BY ACTINOMYCIN D
por: Pogo, Beatríz G. T., et al.
Publicado: (1964)

INTRANUCLEAR FIBRILLAR BODIES IN ACTINOMYCIN D-TREATED OOCYTES
por: Lane, Nancy J.
Publicado: (1969)

Surgery and Actinomycin Improve Survival in Malignant Rhabdoid Tumor
por: Horazdovsky, Ryan, et al.
Publicado: (2013)

Real time US –guided ventricular catheterisation: a single centre retrospective audit
por: Agushi, Erjon, et al.
Publicado: (2015)

Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
por: Arcaroli, J J, et al.
Publicado: (2013)

Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
por: Zhang, H, et al.
Publicado: (2014)

Sphenoid sinus mucosal thickening in the acute phase of pituitary apoplexy
por: Waqar, Mueez, et al.
Publicado: (2017)

Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model
por: Bozec, A, et al.
Publicado: (2008)

Force spectroscopy reveals the DNA structural dynamics that govern the slow binding of Actinomycin D
por: Paramanathan, Thayaparan, et al.
Publicado: (2012)

Proceedings: Interaction of actinomycin D, radiation and yeast cell survival.
por: van Duyse, E., et al.
Publicado: (1975)

THE EFFECTS OF ACTINOMYCIN D ON THE ULTRASTRUCTURE OF THE NUCLEUS OF THE AMPHIBIAN EMBRYONIC CELL
por: Jones, K. W., et al.
Publicado: (1964)

THE DIFFERENTIAL EFFECT OF ACTINOMYCIN D IN NORMAL AND VIRUS-TRANSFORMED CELLS
por: Williams, J. G., et al.
Publicado: (1973)

DETECTION OF DNA BY TRITIATED ACTINOMYCIN D ON ULTRATHIN FROZEN SECTIONS
por: Bernier, Roch, et al.
Publicado: (1972)

Antisense artifacts in transcriptome microarray experiments are resolved by actinomycin D
por: Perocchi, Fabiana, et al.
Publicado: (2007)

MEIOSIS AND INHIBITION OF OVULATION IN MOUSE EGGS TREATED WITH ACTINOMYCIN D
por: Jagiello, Georgiana M.
Publicado: (1969)

THE DIFFERENTIAL SENSITIVITY OF CULTURED CHICK MESODERMAL CELLS TO ACTINOMYCIN D
por: Piper, J. A., et al.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_76jav6vdc8lduqirhepfh04g52